`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`___________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`___________________
`
`
`HOPEWELL PHARMA VENTURES, INC.,
`Petitioner,
`v.
`MERCK SERONO S.A.,
`Patent Owner.
`
`___________________
`
`Case IPR2023-00481
`U.S. Patent No. 8,377,903
`___________________
`
`
`PETITIONER’S UPDATED MANDATORY NOTICES
`PURSUANT TO 37 C.F.R. § 42.8(a)(3)
`
`
`
`
`
`
`
`
`
`Mail Stop "PATENT BOARD"
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`Case IPR2023-00481
`U.S. Patent No. 8,377,903
`Petitioner Hopewell Pharma Ventures, Inc. (“Petitioner”) hereby files these
`
`Updated Mandatory Notices Pursuant to 37 C.F.R. § 42.8(a)(3) to update
`
`Petitioner’s listing of related matters.
`
`I.
`
`RELATED MATTERS
`On February 10, 2023, Petitioner filed a Petition for Inter Partes Review of
`
`U.S. Patent No. 10,849,919 (“’919 patent”), proceeding no. IPR2023-00482. The
`
`’919 patent is also directed to treating Multiple Sclerosis with cladribine, and is
`
`owned by Ares Trading S.A., which is an affiliate of the entity that owns Merck
`
`Serono, S.A., the owner of U.S. Patent No. 8,377,903 (“’903 patent”). Both the
`
`’919 patent and the ’903 patent have been asserted against Petitioner in Merck
`
`KGaA et al. v. Hopewell Pharma Ventures, Inc., Case No. 1:22-cv-01365-GBW
`
`(D. Del.), and it has been asserted in Merck KGaA et al. v. Aurobindo Pharma
`
`USA, Inc. et al., Case No. 1:23-cv-00039-GBW (D. Del.), and Merck KGaA et al.
`
`v. Accord Healthcare, Inc., et al., Case No. 1:22-cv-00974-GBW (D. Del.).
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
` STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`
`/Eldora L. Ellison/
`
`Eldora L. Ellison, Ph.D.
`Lead Attorney for Petitioner
`Registration No. 39,967
`
`- 1 -
`
`
`
`
`
`Date: February 22, 2023
`1100 New York Avenue, N.W.
`Washington, D.C. 20005-3934
`(202) 371-2600
`
`
`
`Case IPR2023-00481
`U.S. Patent No. 8,377,903
`CERTIFICATE OF SERVICE (37 C.F.R. § 42.6(e))
`I certify that the above-captioned PETITIONER’S UPDATED
`
`MANDATORY NOTICES PURSUANT TO 37 C.F.R. § 42.8(a)(3) was served
`
`in its entirety on February 22, 2023, upon the following parties via electronic mail:
`
`Emily R. Whelan (Lead Counsel)
`Deric Geng (Back-up Counsel)
`Cindy Kan (Back-up Counsel)
`WILMER CUTLER PICKERING HALE AND DORR LLP
`Emily.Whelan@wilmerhale.com
`Deric.Geng@wilmerhale.com
`Cindy.Kan@wilmerhale.com
`WHMerckMavencladIPRs@wilmerhale.com
`
`
`
`Respectfully submitted,
`
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`
` /Eldora L. Ellison/
`
`Eldora L. Ellison, Ph.D.
`Lead Attorney for Petitioner
`Registration No. 39,967
`
`
`
`
`
`
`
`
`
`
`
`Date: February 22, 2023
`1100 New York Avenue, N.W.
`Washington, D.C. 20005-3934
`(202) 371-2600
`
`19796926_1.DOCX
`
`
`
`